Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Phase A- 4 Weeks Single Blind	STARTED	Sativex (Phase B)	572
Phase A- 4 Weeks Single Blind	STARTED	Placebo (Phase B)	0
Phase A- 4 Weeks Single Blind	COMPLETED	Sativex (Phase B)	538
Phase A- 4 Weeks Single Blind	COMPLETED	Placebo (Phase B)	0
Phase A- 4 Weeks Single Blind	NOT COMPLETED	Sativex (Phase B)	34
Phase A- 4 Weeks Single Blind	NOT COMPLETED	Placebo (Phase B)	0
Phase B- Responders;12 Week Double-blind	STARTED	Sativex (Phase B)	124
Phase B- Responders;12 Week Double-blind	STARTED	Placebo (Phase B)	117
Phase B- Responders;12 Week Double-blind	COMPLETED	Sativex (Phase B)	109
Phase B- Responders;12 Week Double-blind	COMPLETED	Placebo (Phase B)	115
Phase B- Responders;12 Week Double-blind	NOT COMPLETED	Sativex (Phase B)	15
Phase B- Responders;12 Week Double-blind	NOT COMPLETED	Placebo (Phase B)	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00681538/flow